Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

Suspected adverse drug reactions (ADRs) during treatment with clozapine often prompt therapeutic drug monitoring (TDM) in clinical practice. Currently, there is no official recommendation for pharmacogenetic (PGx) testing in the context of clozapine therapy. In this case report, we demonstrate and d...

Full description

Bibliographic Details
Main Authors: Florine M. Wiss, Samuel S. Allemann, Henriette E. Meyer zu Schwabedissen, Céline K. Stäuble, Thorsten Mikoteit, Markus L. Lampert
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Psychiatry
Subjects:
therapeutic drug monitoring
pharmacogenetic
adverse drug reaction
adherence
clozapine
CYP2D6
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1397876/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1397876/full

Similar Items